1. Home
  2. HURC vs SPRO Comparison

HURC vs SPRO Comparison

Compare HURC & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$22.60

Market Cap

139.9M

Sector

Industrials

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.17

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
SPRO
Founded
1968
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.9M
156.3M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
HURC
SPRO
Price
$22.60
$2.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.6K
1.6M
Earning Date
06-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
111.81
EPS
N/A
N/A
Revenue
$178,554,000.00
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.24
52 Week Low
$14.50
$1.80
52 Week High
$23.75
$3.08

Technical Indicators

Market Signals
Indicator
HURC
SPRO
Relative Strength Index (RSI) 71.11 40.10
Support Level $16.51 $2.12
Resistance Level $23.75 $2.50
Average True Range (ATR) 0.80 0.22
MACD -0.09 -0.02
Stochastic Oscillator 57.63 20.00

Price Performance

Historical Comparison
HURC
SPRO

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: